Jim Simons

Jim Simons Renaissance Technologies

AUM $75.8B
1-Year Est. Return 50.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Quarter Est. Return
1 Year Est. Return
+50.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$75.8B
AUM Growth
+$582M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,038
New
Increased
Reduced
Closed

Top Buys

1 +$633M
2 +$487M
3 +$419M
4
META icon
Meta Platforms (Facebook)
META
+$345M
5
KO icon
Coca-Cola
KO
+$257M

Top Sells

1 +$1.36B
2 +$900M
3 +$583M
4
NVDA icon
NVIDIA
NVDA
+$335M
5
NFLX icon
Netflix
NFLX
+$320M

Sector Composition

1 Technology 21.71%
2 Healthcare 15.16%
3 Consumer Discretionary 11.8%
4 Communication Services 10.53%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIB
3151
Trinity Biotech
TRIB
$17.3M
$178K ﹤0.01%
171,362
+114,397
UTSI icon
3152
UTStarcom
UTSI
$21.8M
$178K ﹤0.01%
70,088
-6,300
COHN icon
3153
Cohen & Co
COHN
$39.3M
$177K ﹤0.01%
15,800
+200
TOON icon
3154
Kartoon Studios
TOON
$39.6M
$175K ﹤0.01%
+237,549
ORIC icon
3155
Oric Pharmaceuticals
ORIC
$801M
$174K ﹤0.01%
14,500
+4,300
SMCL
3156
GraniteShares 2x Long SMCI Daily ETF
SMCL
$37.4M
$174K ﹤0.01%
+11,900
YQ
3157
17 Education & Technology Group
YQ
$36.6M
$174K ﹤0.01%
40,581
+3,751
AREN icon
3158
Arena Group
AREN
$191M
$173K ﹤0.01%
31,700
+15,100
XLO icon
3159
Xilio Therapeutics
XLO
$34.1M
$173K ﹤0.01%
204,700
+40,500
SOTK icon
3160
Sono-Tek
SOTK
$58.3M
$171K ﹤0.01%
38,700
+7,700
HHS icon
3161
Harte-Hanks
HHS
$23.8M
$171K ﹤0.01%
46,000
+7,200
FTHM icon
3162
Fathom Holdings
FTHM
$34M
$171K ﹤0.01%
94,800
-14,700
JOB icon
3163
GEE Group
JOB
$20.2M
$170K ﹤0.01%
824,741
+63,200
ENTX icon
3164
Entera Bio
ENTX
$90.3M
$170K ﹤0.01%
88,400
+24,100
SGRP icon
3165
SPAR Group
SGRP
$19.7M
$169K ﹤0.01%
163,900
-37,400
ROMA icon
3166
Roma Green Finance Ltd
ROMA
$144M
$168K ﹤0.01%
+57,600
MSGM icon
3167
Motorsport Games
MSGM
$16.1M
$167K ﹤0.01%
59,600
+30,400
NSTS icon
3168
NSTS Bancorp
NSTS
$57.2M
$166K ﹤0.01%
14,400
NXTC icon
3169
NextCure
NXTC
$35.6M
$166K ﹤0.01%
28,334
-13,411
FDSB
3170
Fifth District Bancorp
FDSB
$80.8M
$166K ﹤0.01%
+12,000
CARV
3171
DELISTED
Carver Bancorp
CARV
$165K ﹤0.01%
68,600
+18,300
ENLV icon
3172
Enlivex Therapeutics
ENLV
$197M
$164K ﹤0.01%
157,292
-11,100
TOUR
3173
Tuniu
TOUR
$76.7M
$164K ﹤0.01%
171,730
-200
CUE icon
3174
Cue Biopharma
CUE
$31.5M
$163K ﹤0.01%
227,064
+93,600
SABS icon
3175
SAB Biotherapeutics
SABS
$189M
$162K ﹤0.01%
80,840
+69,810